Pelabresib
morphosys
['mpnsm', '#mpn', 'morphosys']
intriguing first results from manifest arm 4 on pelabresib in hu resistant/intolerant et presented at #asco2023 and #eha2023. good to see effects beyond lowering of the platelet count! #mpnsm 
Associate Professor, Leukemia at MD Anderson; myeloproliferative neoplasm expert, NCCN panelist. Tweets reflect my own views; not necessarily my institution's.